9YX-25953-32908
4 vaccinations
7 coded responses
50 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 030 / NH
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Registered in v-safe
-
2021-03-14
Dose 1 — Moderna
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
-
2021-03-28
Survey response — day 14, dose 1MedDRA: Injection site discolouration, Injection site rash, Injection site swelling, Rash, Rash erythematous, Rash papular, Rash pruritic, Skin warm — Feeling: GoodFree text: On day 9, a rash appeared at the injection site. It was itchy, red, raised and warm to touch. It covered most of my upper arm. Over- the- counter hydrocortisone relieved the itching. It's still itchy and discolored but not swollen or warm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — day 21, dose 1MedDRA: Pre-existing disease, Rash, Rash pruritic, Skin discolouration — Feeling: GoodFree text: Last week, I reported a rash on my arm that was resolving. I take Tysabri infusions for MS, and had an infusion this past Mon. On Tues, the rash was back to thre way it had been a week prior. Today, it's better, but still there, itchy and discolored.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Dose 2 — Moderna
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-04-18
Health check-in — day 7, dose 2Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-07-11
-
2021-09-17
Dose 3 — Moderna
- 2021-09-17
-
2021-09-18
Survey response — days 1–6 daily, dose 3MedDRA: Hypersomnia — Feeling: Good · Site: PainFree text: Slept for 10 1/2 hours, which is unusual for me.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
-
2021-12-17
Survey response — 3 months, dose 3MedDRA: Bronchitis, Craniopharyngioma, Nasopharyngitis, Neoplasm, Office visit, Pre-existing disease, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Diagnosed with a craniopharyngioma, but the tumor itself isn't new; they just thought it was something else. Had a cold that developed into bronchitis. (COVID negative) All symptoms have resolved. · Healthcare visit (other): Neurosurgeon for tumorMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2021-12-20
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-18
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-09-09
Dose 4 — ModernaCo-administered: Flu
-
2022-09-10
Survey response — days 1–6 daily, dose 4MedDRA: Adrenal insufficiency, Diabetes mellitus, Growth hormone deficiency, Pituitary gland operation — Feeling: Good · Site: PainFree text: Adrenal insufficiency, growth hormone deficiency, diabetes incipedus due to pituitary surgery since last vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-11
- 2022-09-12
- 2022-09-16
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-10
-
2023-03-10
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-10
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-13
- 2023-03-14
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Moderna | |
| 2 | 2021-04-11 | Moderna | |
| 3 | 2021-09-17 | Moderna | No |
| 4 | 2022-09-09 | Moderna | Flu |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 6 — day 14, dose 1
Symptoms: On day 9, a rash appeared at the injection site. It was itchy, red, raised and warm to touch. It covered most of my upper arm. Over- the- counter hydrocortisone relieved the itching. It's still itchy and discolored but not swollen or warm.
Release 6 — day 21, dose 1
Symptoms: Last week, I reported a rash on my arm that was resolving. I take Tysabri infusions for MS, and had an infusion this past Mon. On Tues, the rash was back to thre way it had been a week prior. Today, it's better, but still there, itchy and discolored. cut off by CDC
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Slept for 10 1/2 hours, which is unusual for me.
Release 10 — 3 months, dose 3
Symptoms: Diagnosed with a craniopharyngioma, but the tumor itself isn't new; they just thought it was something else. Had a cold that developed into bronchitis. (COVID negative) All symptoms have resolved.
Healthcare visit (other): Neurosurgeon for tumor
Release 11 — 6 months, dose 3
Symptoms: Covid
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Adrenal insufficiency, growth hormone deficiency, diabetes incipedus due to pituitary surgery since last vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Neoplasm | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Craniopharyngioma | · | · | ✓ |
| SD | Injection site discolouration | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash papular | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Skin discolouration | ✓ | ✓ | ✓ |
| SD | Skin warm | ✓ | ✓ | ✓ |
| SRO | Adrenal insufficiency | · | · | ✓ |
| SRO | Diabetes mellitus | · | · | ✓ |
| SRO | Growth hormone deficiency | · | · | ✓ |
| SRO | Hypersomnia | · | · | ✓ |
| SRO | Pituitary gland operation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release